1. Home
  2. TAOP vs REVB Comparison

TAOP vs REVB Comparison

Compare TAOP & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TAOP
  • REVB
  • Stock Information
  • Founded
  • TAOP 1993
  • REVB 2020
  • Country
  • TAOP China
  • REVB United States
  • Employees
  • TAOP N/A
  • REVB N/A
  • Industry
  • TAOP Computer Software: Prepackaged Software
  • REVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • TAOP Technology
  • REVB Health Care
  • Exchange
  • TAOP Nasdaq
  • REVB Nasdaq
  • Market Cap
  • TAOP 2.9M
  • REVB 3.4M
  • IPO Year
  • TAOP N/A
  • REVB N/A
  • Fundamental
  • Price
  • TAOP $2.62
  • REVB $1.29
  • Analyst Decision
  • TAOP
  • REVB
  • Analyst Count
  • TAOP 0
  • REVB 0
  • Target Price
  • TAOP N/A
  • REVB N/A
  • AVG Volume (30 Days)
  • TAOP 350.3K
  • REVB 202.7K
  • Earning Date
  • TAOP 12-08-2025
  • REVB 11-07-2025
  • Dividend Yield
  • TAOP N/A
  • REVB N/A
  • EPS Growth
  • TAOP N/A
  • REVB N/A
  • EPS
  • TAOP N/A
  • REVB N/A
  • Revenue
  • TAOP $36,196,786.00
  • REVB N/A
  • Revenue This Year
  • TAOP N/A
  • REVB N/A
  • Revenue Next Year
  • TAOP N/A
  • REVB N/A
  • P/E Ratio
  • TAOP N/A
  • REVB N/A
  • Revenue Growth
  • TAOP N/A
  • REVB N/A
  • 52 Week Low
  • TAOP $1.81
  • REVB $1.15
  • 52 Week High
  • TAOP $24.75
  • REVB $60.48
  • Technical
  • Relative Strength Index (RSI)
  • TAOP 43.84
  • REVB 37.34
  • Support Level
  • TAOP $1.81
  • REVB $1.28
  • Resistance Level
  • TAOP $2.80
  • REVB $1.30
  • Average True Range (ATR)
  • TAOP 0.29
  • REVB 0.09
  • MACD
  • TAOP -0.01
  • REVB 0.02
  • Stochastic Oscillator
  • TAOP 50.94
  • REVB 25.98

About TAOP Taoping Inc.

Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

Share on Social Networks: